Universal Biotech

Shanghai-based, supplying life-science reagents, equipment, consumables and integrated technical services to higher-education institutions, research institutes, hospitals and biopharmaceutical companies, and acting as an authorised East China distributor for lines including BD Pharmingen.

Country: China

China

Coverage

	CN	EU	US
digital-it	✓	✓	✓

Regulatorsfdaemanmpa

Verifiable facts

Fact	Value	Source
Revenue	CNY 1.08 billion (2025)	static.cninfo.com.cn · money.finance.sina.com.cn
Headcount	698 employees	quote.cfi.cn
Production site	Nanjing R&D and production operation base (includes GMP-level production workshop)	static.cninfo.com.cn · money.finance.sina.com.cn
Capacity	The completion of the Nanjing R&D and production base is expected to significantly increase the production capacity for self-developed products such as recombinant proteins and IVD antibodies.	static.cninfo.com.cn · money.finance.sina.com.cn
Certification	AEO advanced certification, network security level 3 certification	static.cninfo.com.cn
Regulatory approval	Operates under various licenses including Third-class medical device operation, Second-class value-added telecommunications business, and Hazardous chemical operation. medium confidence	quote.cfi.cn
Funding	Shanghai municipal government provides various subsidies, including up to RMB 30 million for eligible R&D projects and a 50 percent subsidy on low-interest loans for technological transformation or production expansion. medium confidence	itif.org

Independent sources: itif.org · money.finance.sina.com.cn · quote.cfi.cn · static.cninfo.com.cn

Technologies

Name	Cluster	Risk
Lab-equipment management & procurement	digital-it	Low	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.